Startup out of Stanford scores $40M from Westlake, Lightspeed to find novel targets for immunotherapy

In the last decade, immunotherapy, which involves the usage of a patient’s own immune cells to fight cancers, has gained great momentum. In one variation, the treatment involves removing a patient’s T cells, a type of white blood cell, and enabling them to recognize proteins that are only present in…